Company intelligence / Profile preview

Weitian Group

New York City, New York, United States

Ownership: Private
Development stage: Other

Overview

Weitian Group is a full-service investor relations consultancy specializing in small- to micro-cap companies, with a primary focus on U.S. and Chinese cross-border financial communications. It is not a biotech, pharma, or healthcare company and does not develop drugs, platforms, or therapies. Its core business is advising clients on investor relations, particularly in the context of capital markets involving the U.S. and China. The company is currently not active, with no known investments in over a decade.

Industry: Consulting

Beyond the preview

Go deeper on Weitian Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weitian Group.

Explore the full profile